HEOR Services - Global Strategic Business Report

The global market for HEOR Services was estimated at US$1.3 Billion in 2024 and is projected to reach US$2.5 Billion by 2030, growing at a CAGR of 12.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the HEOR Services market.

Global HEOR Services Market - Key Trends & Drivers Summarized

Why Are HEOR Services Becoming Essential in Healthcare Decision-Making?

Health Economics and Outcomes Research (HEOR) services have become a critical component of healthcare decision-making, helping pharmaceutical companies, payers, and regulatory bodies assess the economic value and real-world impact of medical treatments. These services provide data-driven insights on the cost-effectiveness, safety, and quality of healthcare interventions, ensuring that stakeholders make informed reimbursement and pricing decisions. With rising healthcare costs and the growing emphasis on value-based care, HEOR services play a crucial role in determining drug pricing strategies, formulary placements, and patient access programs. Additionally, regulatory agencies such as the FDA and EMA are increasingly relying on HEOR data to evaluate new drug approvals and post-market surveillance. As healthcare systems shift toward evidence-based medicine, the demand for HEOR services continues to grow.

How Are Technological Advancements Enhancing HEOR Services?

Technological advancements, including artificial intelligence, big data analytics, and real-world evidence (RWE) platforms, are transforming the HEOR landscape. AI-driven predictive modeling is enabling more accurate forecasting of treatment outcomes and cost-effectiveness. The integration of electronic health records (EHRs) and wearable device data is improving real-world evidence generation, allowing for more comprehensive health outcome assessments. Blockchain technology is also being explored to enhance data security and transparency in HEOR studies. Additionally, advancements in health informatics are enabling faster and more efficient data processing, reducing the time required to generate insights for healthcare decision-making. These innovations are making HEOR services more precise, scalable, and impactful in guiding healthcare policy and investment decisions.

Why Is Demand for HEOR Services Increasing Among Pharmaceutical Companies?

Pharmaceutical companies are increasingly relying on HEOR services to navigate complex pricing and reimbursement landscapes, optimize market access strategies, and demonstrate the value of their products to healthcare payers. The growing emphasis on personalized medicine and specialty drugs has heightened the need for robust health economic assessments, ensuring that innovative therapies remain accessible and affordable. Additionally, HEOR services are becoming essential in conducting comparative effectiveness research, helping pharmaceutical firms differentiate their products from competitors. The expansion of biosimilars and gene therapies has further increased the need for HEOR-driven evaluations, as companies seek to justify premium pricing models. These factors are driving substantial growth in the HEOR services market.

What Are the Key Factors Driving the Growth of the HEOR Services Market?

The growth in the HEOR services market is driven by rising healthcare expenditures, increasing regulatory requirements for real-world evidence, and advancements in data analytics. The transition toward value-based healthcare models has amplified the demand for economic and outcomes research, ensuring that treatments provide both clinical and financial benefits. Additionally, the expansion of healthcare infrastructure in emerging markets is creating new opportunities for HEOR service providers, as governments seek to optimize healthcare spending. The growing number of clinical trials and the need for post-market surveillance are further fueling market expansion. As healthcare systems become more data-driven, HEOR services will continue to play a pivotal role in shaping drug development, pricing, and reimbursement strategies.

Scope of Study:

The report analyzes the HEOR Services market in terms of units by the following Segments, and Geographic Regions/Countries:

• Segments: Service (Economic Modelling / Evaluation Service, Real-World Data Analysis & Information Systems Service, Clinical Outcome Service, Market Access Solutions & Reimbursement Service, Other Services); Service Provider (Consultancy Service Provider, Contract Research Organizations Service Provider); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Biotech / Pharma Companies End-Use, Government Organizations End-Use, Other End-Uses)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Economic Modelling / Evaluation Service segment, which is expected to reach US$915.6 Million by 2030 with a CAGR of a 10.3%. The Real-World Data Analysis & Information Systems Service segment is also set to grow at 13.0% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $343.5 Million in 2024, and China, forecasted to grow at an impressive 16.2% CAGR to reach $521.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global HEOR Services Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global HEOR Services Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global HEOR Services Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Adelphi Values, Artia Solutions, Avalere Health, Avalon Health Economics, Axtria, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this HEOR Services market report include:

• Adelphi Values
• Artia Solutions
• Avalere Health
• Avalon Health Economics
• Axtria, Inc.
• Boston Strategic Partners
• EVERSANA
• Health Research and Analysis (HRA)
• Hull Associates
• ICON plc
• Informa plc
• IQVIA
• Lindus Health
• McKesson Corporation
• Medlior Health Outcomes Research Ltd.
• Optum, Inc. (UnitedHealth Group)
• PharmaLex GmbH
• Picnic Health
• Syneos Health
• Wellth

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.